Medeligo 17+

LiveMed Media Ltd.

    • Ücretsiz
    • Uygulama İçi Satın Alımlar Sunar

iPhone Ekran Görüntüleri

Açıklama

Medeligo® provides instant access to the latest oncology literature and information for treatment, procedure, testing, and management information across all oncology subspecialties.

FINGERTIP ACCESS TO THE LATEST ONCOLOGY INFORMATION

- AI-powered search engineered by technologists and medical librarians
- Effortless UI gets to answers in seconds
- Covers more than 2,000 solid tumors and cancers, including the WHO Classification of Tumours
- Real-time searches provide the latest information available
- Searches only the most trusted medical journals, databases, and information resources
- Primary source material: unfiltered, unbiased, uncurated

Benefits include:

- Find and read the latest oncology literature in seconds
- Watch relevant videos and browse images
- Prepare for patient rounds, consults, and surgeries
- Answer patient-specific questions quickly at tumor boards
- Share, print, or save articles

Limited introductory price of $49.99 (Reg. $149.99) for the All Access (1 year) subscription — includes a risk-free 3-month trial.

To learn more, please visit www.medeligo.com.

After the free trial period, your subscription will continue for $49.99/year, and your iTunes account will be charged. If you do not wish to continue your subscription after your free trial ends, turn off auto-renew in your Account Settings 24 hours before the end of your free trial.
Subscriptions will automatically renew when they expire unless you turn off auto-renew at least 24 hours before the end of your subscription period. Your account will be charged $49.99 for renewal within 24 hours before the end of your subscription period. You can manage your subscription and turn off auto-renew by going to your Account Settings.
Any unused portion of a free trial period, if offered, will be forfeited when the user purchases a subscription to that publication, where applicable.

You can read more about our terms and conditions here:
Privacy policy: http://medeligo.com/privacy-policy/
Terms of service: http://medeligo.com/terms-of-service/

Yenilikler

Sürüm 1.5.4

• Users can now delete their accounts.

Uygulama Gizliliği

LiveMed Media Ltd. adlı geliştirici, uygulamanın gizlilik politikasına göre verilerin aşağıda açıklandığı gibi işlenebileceğini bildirdi. Daha fazla bilgi için geliştiricinin gizlilik politikası bölümüne bakın.

Sizinle İlişkilendiri­len Veriler

Şu veriler toplanabilir ve kimliğinizle ilişkilendirilebilir:

  • Kişi Bilgileri
  • Kimlik Tanıtıcılar
  • Kullanım Verileri

Sizinle İlişkilendiril­me­yen Veriler

Şu veriler toplanabilir ancak kimliğinizle ilişkilendirilmez:

  • Tanılar

Gizlilik uygulamaları, kullandığınız özellikler veya yaşınız gibi faktörlere göre değişiklik gösterebilir. Ayrıntılı Bilgi

Diğer Beğenebilecekleriniz

Washington Manual of Oncology
Tıp
Neuro-oncology: WTD
Tıp
Kidney Cancer Manager
Tıp
Breast Cancer Manager
Tıp
ALTAI Oncology
Tıp
Bladder Cancer Manager
Tıp